Industry Verticals »

All Categories

Insights »

About TMR »

Autoimmune Disease Diagnostics Market Forecast Report, 2019-2027

Autoimmune Disease Diagnostics Market (Test Type - Antinuclear Antibody Tests, Autoantibody Tests, Complete Blood Count (CBC), Comprehensive Metabolic Panel, C-reactive Protein (CRP), Erythrocyte Sedimentation Rate (ESR), and Urinalysis; Disease Type - Graves’ Disease, Hashimoto’s Thyroiditis, Multiple Sclerosis, Rheumatoid Arthritis, Systemic Lupus Erythematosus (Lupus), and Type 1 Diabetes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global autoimmune disease diagnostics market for the historical period 2017–2018 and forecast period 2019–2027, high prevalence of autoimmune diseases across the world, Increased health care expenditure globally, Growing awareness among people about autoimmune diseases are projected to drive the global autoimmune disease diagnostics market during the forecast period
  • According to the report, the global autoimmune disease diagnostics market was valued at US$ 14.4 Bn in 2018 and is anticipated to expand at a CAGR of 3.8% from 2019 to 2027

High Prevalence of Autoimmune Diseases across the World and Increased Health Care Expenditure Globally: Key Drivers

  • Rise in the prevalence of autoimmune diseases directly affects the growth and development of the autoimmune disease diagnostics market. The market is estimated to grow at a high rate due to rising incidence of diseases such as systemic lupus erythematosus, rheumatoid arthritis, Hashimoto’s thyroiditis, Graves’ disease, and type 1 diabetes.
  • According to the National Institutes of Health, up to 23.5 million Americans (more than seven percent of the population) suffer from an autoimmune disease - and the prevalence is rising. The rising prevalence of autoimmune diseases is likely to fuel the growth of the autoimmune disease diagnostics market. Therefore, consistent increase in the autoimmune patient population across the world has been identified as one of the major factors driving the autoimmune disease diagnostics market.
  • Technological advancements in diagnostic techniques for autoimmune diseases have helped extend the life expectancy of people and led to increased cost of treatment. Governments across the world are increasing their spending to provide better health care services. For instance, an analysis based on preliminary government data by the Centers for Medicare & Medicaid Services revealed that health care spending in the U.S. increased by 5% in 2014 as compared to 3.6% in 2013. Apart from developed countries, health care spending is also rising in developing parts of the world such as India and China. These countries are focusing on providing better health care services to a large population base.

Growing Awareness among People about Autoimmune Diseases Boost Market Growth

  • Increasing awareness and knowledge about autoimmune diseases among patients and care-givers would significantly contribute to the growth of the autoimmune disease diagnostics market
  • AARDA initiated the formation of the Center for Autoimmune Disease Research at Johns Hopkins University Medical Center and the NIH established Centers of Excellence in autoimmune diseases. AARDA also sponsors various programs and workshops aimed at bringing together researchers from different disciplines involved in autoimmune research. These factors are likely to fuel the growth of the market.
  • Rising awareness among people and increasing government initiatives are the major factors driving the autoimmune disease diagnostics market

Competitive Pricing and Equipment Costs to Hamper Market

  • The autoimmune disease diagnostics market is characterized by intense competition from local manufacturers that offer products at low cost. This is expected to hamper market growth as competition could lead to fall in prices of the products.
  • Moreover, with continuous technological developments in the autoimmune disease diagnostics market with respect to accuracy and efficiency, manufacturers are expected to provide up-to-date solutions to the customers. Customers are in fact hesitant to opt for cost-intensive upgrade procedures as they need to invest more capital for technologically advanced procedures and products.
  • Therefore, intense competition among players leading to low cost of products and procedures would hamper the growth of the autoimmune disease diagnostics market during the forecast period from 2019 to 2027

Global Autoimmune Disease Diagnostics Market: Competitive Landscape

  • This report profiles major players in the global autoimmune disease diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global autoimmune disease diagnostics market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global autoimmune disease diagnostics market are
    • Abbott Laboratories, Inc.,
    • Beckman Coulter, Inc. ,
    • bioMérieux SA,
    • Bio-Rad Laboratories,
    • F. Hoffmann-La, Roche Ltd.,
    • Inova Diagnostics, Inc.,
    • Quest Diagnostics,
    • SQI Diagnostics, Inc.,
    • Siemens Healthcare among others

Global Autoimmune Disease Diagnostics Market: Key Developments

Key players in the global autoimmune disease diagnostics market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global autoimmune disease diagnostics market. A few expansion strategies adopted by players operating in the global autoimmune disease diagnostics market are:

  • In March 2019, Abbott received CE Mark for its Alinity m diagnostics system and assays. This new technology will help keep up with the growing demand for infectious disease testing.
  • In June 2016, Beckman Coulter Diagnostics announced that it is ramping up its commercial focus on the Indian subcontinent with a series of steps that will help substantially increase its customer base- small- to large-volume hospital pathology laboratories.
  • In February 2019, Roche have entered into a definitive merger agreement with Spark Therapeutics, Inc. at a price of US$ 114.50 per share in an all-cash transaction.

The report on the global autoimmune disease diagnostics market discussed individual strategies, followed by company profiles of manufacturers of autoimmune disease diagnostics. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global autoimmune disease diagnostics market.

Global Autoimmune Disease Diagnostics Market - Segmentation

Test Type
  • Antinuclear Antibody Test
  • Autoantibody Test
  • Complete Blood Count (CBC)
  • Comprehensive Metabolic Panel
  • C-reactive Protein (CRP) Test
  • Erythrocyte Sedimentation Rate (ESR)
  • Urinalysis
  • Others

Disease Type
  • Graves’ Disease
  • Hashimoto’s Thyroiditis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • SLE (Lupus)
  • Type 1 Diabetes
  • Others

Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of autoimmune disease diagnostics market?

Autoimmune disease diagnostics market to reach a valuation of US$ 14.4 Bn by 2027

What is the anticipated CAGR of the autoimmune disease diagnostics market in the forecast period?

Autoimmune disease diagnostics market to expand at a CAGR of 3.8% from 2019 to 2027

What are the key driving factors for the growth of the autoimmune disease diagnostics market?

Autoimmune disease diagnostics market is driven by increasing awareness among people related to autoimmune diseases

Who are the key players in the global autoimmune disease diagnostics market?

Key players in the global autoimmune disease diagnostics market include Abbott Laboratories, Inc., Beckman Coulter, Inc., bioMérieux SA, Bio-Rad Laboratories, F. Hoffmann-La, Roche Ltd.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Autoimmune Disease Diagnostics Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Test Type Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Autoimmune Disease Diagnostics Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Technological Development

        5.2. Disease Prevalence & Incidence Cases

    6. Global Autoimmune Disease Diagnostics Market Analysis and Forecast, by Test Type

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Autoimmune Disease Diagnostics Market Value Forecast, by Test Type, 2017–2027

            6.2.1. Antinuclear Antibody Test

            6.2.2. Autoantibody Test

            6.2.3. Complete Blood Count (CBC)

            6.2.4. Comprehensive Metabolic Panel

            6.2.5. C-reactive Protein (CRP) Test

            6.2.6. Erythrocyte Sedimentation Rate (ESR)

            6.2.7. Urinalysis

            6.2.8. Others

        6.3. Global Autoimmune Disease Diagnostics Market Attractiveness, by Test Type

    7. Global Autoimmune Disease Diagnostics Market Analysis and Forecast, by Disease Type

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global Autoimmune Disease Diagnostics Market Value Forecast, by Disease Type, 2017–2027

            7.2.1. Graves’ Disease

            7.2.2. Hashimoto’s Thyroiditis

            7.2.3. Multiple Sclerosis

            7.2.4. Rheumatoid Arthritis

            7.2.5. SLE (Lupus)

            7.2.6. Type 1 Diabetes

            7.2.7. Others

        7.3. Global Autoimmune Disease Diagnostics Market Attractiveness, by Disease Type

    8. Global Autoimmune Disease Diagnostics Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Global Autoimmune Disease Diagnostics Market Value Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. North America Autoimmune Disease Diagnostics Market Attractiveness, by Region

    9. North America Autoimmune Disease Diagnostics Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. North America Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

            9.2.1. Antinuclear Antibody Test

            9.2.2. Autoantibody Test

            9.2.3. Complete Blood Count (CBC)

            9.2.4. Comprehensive Metabolic Panel

            9.2.5. C-reactive Protein (CRP) Test

            9.2.6. Erythrocyte Sedimentation Rate (ESR)

            9.2.7. Urinalysis

            9.2.8. Others

        9.3. North America Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

            9.3.1. Graves’ Disease

            9.3.2. Hashimoto’s Thyroiditis

            9.3.3. Multiple Sclerosis

            9.3.4. Rheumatoid Arthritis

            9.3.5. SLE (Lupus)

            9.3.6. Type 1 Diabetes

            9.3.7. Others

        9.4. North America Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2027

            9.4.1. U.S.

            9.4.2. Canada

        9.5. North America Autoimmune Disease Diagnostics Market Attractiveness Analysis

            9.5.1. By Test Type

            9.5.2. By Disease Type

            9.5.3. By Country

    10. Europe Autoimmune Disease Diagnostics Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Europe Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

            10.2.1. Antinuclear Antibody Test

            10.2.2. Autoantibody Test

            10.2.3. Complete Blood Count (CBC)

            10.2.4. Comprehensive Metabolic Panel

            10.2.5. C-reactive Protein (CRP) Test

            10.2.6. Erythrocyte Sedimentation Rate (ESR)

            10.2.7. Urinalysis

            10.2.8. Others

        10.3. Europe Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

            10.3.1. Graves’ Disease

            10.3.2. Hashimoto’s Thyroiditis

            10.3.3. Multiple Sclerosis

            10.3.4. Rheumatoid Arthritis

            10.3.5. SLE (Lupus)

            10.3.6. Type 1 Diabetes

            10.3.7. Others

        10.4. Europe Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Europe Autoimmune Disease Diagnostics Market Attractiveness Analysis

            10.5.1. By Test Type

            10.5.2. By Disease Type

            10.5.3. By Country/Sub-region

    11. Asia Pacific Autoimmune Disease Diagnostics Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Asia Pacific Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

            11.2.1. Antinuclear Antibody Test

            11.2.2. Autoantibody Test

            11.2.3. Complete Blood Count (CBC)

            11.2.4. Comprehensive Metabolic Panel

            11.2.5. C-reactive Protein (CRP) Test

            11.2.6. Erythrocyte Sedimentation Rate (ESR)

            11.2.7. Urinalysis

            11.2.8. Others

        11.3. Asia Pacific Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

            11.3.1. Graves’ Disease

            11.3.2. Hashimoto’s Thyroiditis

            11.3.3. Multiple Sclerosis

            11.3.4. Rheumatoid Arthritis

            11.3.5. SLE (Lupus)

            11.3.6. Type 1 Diabetes

            11.3.7. Others

        11.4. Asia Pacific Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Asia Pacific Autoimmune Disease Diagnostics Market Attractiveness Analysis

            11.5.1. By Test Type

            11.5.2. By Disease Type

            11.5.3. By Country/Sub-region

    12. Latin America Autoimmune Disease Diagnostics Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Latin America Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

            12.2.1. Antinuclear Antibody Test

            12.2.2. Autoantibody Test

            12.2.3. Complete Blood Count (CBC)

            12.2.4. Comprehensive Metabolic Panel

            12.2.5. C-reactive Protein (CRP) Test

            12.2.6. Erythrocyte Sedimentation Rate (ESR)

            12.2.7. Urinalysis

            12.2.8. Others

        12.3. Latin America Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

            12.3.1. Graves’ Disease

            12.3.2. Hashimoto’s Thyroiditis

            12.3.3. Multiple Sclerosis

            12.3.4. Rheumatoid Arthritis

            12.3.5. SLE (Lupus)

            12.3.6. Type 1 Diabetes

            12.3.7. Others

        12.4. Latin America Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America Latin America

        12.5. Latin America Autoimmune Disease Diagnostics Market Attractiveness Analysis

            12.5.1. By Test Type

            12.5.2. By Disease Type

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Autoimmune Disease Diagnostics Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Middle East & Africa Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

            13.2.1. Antinuclear Antibody Test

            13.2.2. Autoantibody Test

            13.2.3. Complete Blood Count (CBC)

            13.2.4. Comprehensive Metabolic Panel

            13.2.5. C-reactive Protein (CRP) Test

            13.2.6. Erythrocyte Sedimentation Rate (ESR)

            13.2.7. Urinalysis

            13.2.8. Others

        13.3. Middle East & Africa Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

            13.3.1. Graves’ Disease

            13.3.2. Hashimoto’s Thyroiditis

            13.3.3. Multiple Sclerosis

            13.3.4. Rheumatoid Arthritis

            13.3.5. SLE (Lupus)

            13.3.6. Type 1 Diabetes

            13.3.7. Others

        13.4. Middle East & Africa Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Middle East & Africa Autoimmune Disease Diagnostics Market Attractiveness Analysis

            13.5.1. By Test Type

            13.5.2. By Disease Type

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (by Tier and Size of companies)

        14.2. Market Share / Position Analysis, by Company, 2018

        14.3. Competitive Business Strategies

        14.4. Company Profiles

            14.4.1. Abbott Laboratories, Inc.

                14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.1.2. Financial Analysis

                14.4.1.3. Growth Strategies

                14.4.1.4. SWOT Analysis

            14.4.2. Beckman Coulter, Inc.

                14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.2.2. Financial Analysis

                14.4.2.3. Growth Strategies

                14.4.2.4. SWOT Analysis

            14.4.3. bioMérieux SA  

                14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.3.2. Financial Analysis

                14.4.3.3. Growth Strategies

                14.4.3.4. SWOT Analysis

            14.4.4. Bio-Rad Laboratories  

                14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.4.2. Financial Analysis

                14.4.4.3. Growth Strategies

                14.4.4.4. SWOT Analysis

            14.4.5. F. Hoffmann-La Roche Ltd.

                14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.5.2. Financial Analysis

                14.4.5.3. Growth Strategies

                14.4.5.4. SWOT Analysis

            14.4.6. Inova Diagnostics, Inc.

                14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.6.2. Financial Analysis

                14.4.6.3. Growth Strategies

                14.4.6.4. SWOT Analysis

            14.4.7. Quest Diagnostics

                14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.7.2. Financial Analysis

                14.4.7.3. Growth Strategies

                14.4.7.4. SWOT Analysis

            14.4.8. Siemens Healthcare

                14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.8.2. Financial Analysis

                14.4.8.3. Growth Strategies

                14.4.8.4. SWOT Analysis

            14.4.9. SQI Diagnostics, Inc.

                14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.9.2. Growth Strategies

                14.4.9.3. SWOT Analysis

    List of Table

    Table 1     Global Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

    Table 2     Global Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

    Table 3     Global Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 4     North America Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 5     North America Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

    Table 6     North America Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

    Table 7     Europe Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 8     Europe Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

    Table 9     Europe Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

    Table 10     Asia Pacific Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 11     Asia Pacific Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

    Table 12     Asia Pacific Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

    Table 13     Latin America Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 14     Latin America Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

    Table 15     Latin America Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

    Table 16     Middle East & Africa Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 17     Middle East & Africa Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

    Table 18     Middle East & Africa Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2017–2027

    List of Figure

    Figure 1     Global Autoimmune Disease Diagnostics Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

    Figure 2     Global Autoimmune Disease Diagnostics Market Value (US$ Mn) and Forecast, 2019–2027

    Figure 3     Global Autoimmune Disease Diagnostics Market Value Share (%), by Test Type, 2018

    Figure 4     Global Autoimmune Disease Diagnostics Market Value Share (%), by Disease Type, 2018

    Figure 5     Global Autoimmune Disease Diagnostics Market Value Share (%), by Region, 2018

    Figure 6     Global Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

    Figure 7     Global Autoimmune Disease Diagnostics Market Attractiveness, by Test Type, 2019–2027

    Figure 8     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antinuclear Antibody Test, 2017–2027

    Figure 9     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Autoantibody Test, 2017–2027

    Figure 10     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Complete Blood Count (CBC), 2017–2027

    Figure 11     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Comprehensive Metabolic Panel, 2017–2027

    Figure 12     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by C-reactive Protein (CRP) Test, 2017–2027

    Figure 13     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Erythrocyte Sedimentation Rate (ESR), 2017–2027

    Figure 14     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urinalysis, 2017–2027

    Figure 15     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

    Figure 16     Global Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2018 and 2027

    Figure 17     Global Autoimmune Disease Diagnostics Market Attractiveness, by Disease Type, 2019–2027

    Figure 18     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Graves’ Disease, 2017–2027

    Figure 19     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hashimoto’s Thyroiditis, 2017–2027

    Figure 20     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Multiple Sclerosis, 2017–2027

    Figure 21     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Rheumatoid Arthritis, 2017–2027

    Figure 22     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by SLE (Lupus), 2017–2027

    Figure 23     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Type 1 Diabetes, 2017–2027

    Figure 24     Global Autoimmune Disease Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

    Figure 25     Global Autoimmune Disease Diagnostics Market Value Share, by Region, 2018 and 2027

    Figure 26     Global Autoimmune Disease Diagnostics Market Attractiveness, by Region, 2019–2027

    Figure 27     North America Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 28     North America Autoimmune Disease Diagnostics Market Value Share Analysis, by Country, 2018 and 2027

    Figure 29     North America Autoimmune Disease Diagnostics Market Attractiveness, by Country, 2019–2027

    Figure 30     North America Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

    Figure 31     North America Autoimmune Disease Diagnostics Market Attractiveness, by Test Type, 2019–2027

    Figure 32     North America Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2018 and 2027

    Figure 33     North America Autoimmune Disease Diagnostics Market Attractiveness, by Disease Type, 2019–2027

    Figure 34     Europe Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 35     Europe Autoimmune Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 36     Europe Autoimmune Disease Diagnostics Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 37     Europe Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

    Figure 38     Europe Autoimmune Disease Diagnostics Market Attractiveness, by Test Type, 2019–2027

    Figure 39     Europe Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2018 and 2027

    Figure 40     Europe Autoimmune Disease Diagnostics Market Attractiveness, by Disease Type, 2019–2027

    Figure 41     Asia Pacific Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 42     Asia Pacific Autoimmune Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 43     Asia Pacific Autoimmune Disease Diagnostics Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 44     Asia Pacific Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

    Figure 45     Asia Pacific Autoimmune Disease Diagnostics Market Attractiveness, by Test Type, 2019–2027

    Figure 46     Asia Pacific Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2018 and 2027

    Figure 47     Asia Pacific Autoimmune Disease Diagnostics Market Attractiveness, by Disease Type, 2019–2027

    Figure 48     Latin America Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 49     Latin America Autoimmune Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 50     Latin America Autoimmune Disease Diagnostics Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 51     Latin America Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

    Figure 52     Latin America Autoimmune Disease Diagnostics Market Attractiveness, by Test Type, 2019–2027

    Figure 53     Latin America Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2018 and 2027

    Figure 54     Latin America Autoimmune Disease Diagnostics Market Attractiveness, by Disease Type, 2019–2027

    Figure 55     Middle East & Africa Autoimmune Disease Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

    Figure 56     Middle East & Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 57     Middle East & Africa Autoimmune Disease Diagnostics Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 58      Middle East & Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

    Figure 59      Middle East & Africa Autoimmune Disease Diagnostics Market Attractiveness, by Test Type, 2019–2027

    Figure 60      Middle East & Africa Autoimmune Disease Diagnostics Market Value Share Analysis, by Disease Type, 2018 and 2027

    Figure 61     Middle East & Africa Autoimmune Disease Diagnostics Market Attractiveness, by Disease Type, 2019–2027

Copyright © Transparency Market Research, Inc. All Rights reserved

Autoimmune Disease Diagnostics Market Forecast Report, 2019-2027

Schedule a Call